Comparative Bioavailability of Two Formulations of Biopharmaceutical Classification System (BCS) Class IV Drugs: A Case Study of Lopinavir/Ritonavir
| Autor: | Saeed, Ahmed M., Schmidt, Jeffery M., Munasinghe, Wijith P., Vallabh, Bhadrish K., Jarvis, Michael F., Morris, John B., Mostafa, Nael M. |
|---|---|
| Zdroj: | In Journal of Pharmaceutical Sciences December 2021 110(12):3963-3968 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|